About The Study: Bariatric metabolic surgery was associated with greater reduced mortality compared with first-generation glucagon-like peptide-1 receptor agonists (GLP-1RAs) among individuals with a diabetes duration of 10 years or less, mediated via greater weight loss in this cohort study. No differences in the risk for mortality were observed between the treatment modalities among individuals with a longer duration of diabetes, nor in the occurrence of nonfatal major adverse cardiovascular events among all patients.
About The Study: Bariatric metabolic surgery was associated with greater reduced mortality compared with first-generation glucagon-like peptide-1 receptor agonists (GLP-1RAs) among individuals with a diabetes duration of 10 years or less, mediated via greater weight loss in this cohort study. No differences in the risk for mortality were observed between the treatment modalities among individuals with a longer duration of diabetes, nor in the occurrence of nonfatal major adverse cardiovascular events among all patients.
Corresponding Author: To contact the corresponding author, Orna Reges, Ph.D., email orna.reges@gmail.com.
To access the embargoed study: Visit our For The Media website at this link
(doi:10.1001/jamanetworkopen.2024.15392)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Journal
JAMA Network Open
Cite Scienmag News
Ophelia Keating. (June 7, 2024). Bariatric metabolic surgery vs glucagon-like peptide-1 receptor agonists and mortality. Scienmag. https://scienmag.com/bariatric-metabolic-surgery-vs-glucagon-like-peptide-1-receptor-agonists-and-mortality/
Ophelia Keating. "Bariatric metabolic surgery vs glucagon-like peptide-1 receptor agonists and mortality." Scienmag, 7 June 2024, https://scienmag.com/bariatric-metabolic-surgery-vs-glucagon-like-peptide-1-receptor-agonists-and-mortality/. Accessed 4 September 2026.
Ophelia Keating. "Bariatric metabolic surgery vs glucagon-like peptide-1 receptor agonists and mortality." Scienmag. June 7, 2024. https://scienmag.com/bariatric-metabolic-surgery-vs-glucagon-like-peptide-1-receptor-agonists-and-mortality/
